Morbid

14 drugs in development·13 companies·1 clinical trial

Drug Pipeline by Phase

Approved(12)

Drug	Company
daurismo	PFIZER INC (PFE)
exforge hct	Novartis AG (NVS)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
nebivolol	ANI PHARMACEUTICALS INC (ANIP)
olmesartan medoxomil	Amneal Pharmaceuticals, Inc. (AMRX)
romvimza	Deciphera Pharmaceuticals, Inc. (DCPH)
saxenda	Novo Nordisk A/S (NVO)
telmisartan	Inventiva S.A. (IVA)
venetoclax	DR REDDYS LABORATORIES LTD (RDY)
Zepbound	ELI LILLY & Co (LLY)
Zepbound®	ELI LILLY & Co (LLY)
zydelig	GILEAD SCIENCES, INC. (GILD)

Phase 3(1)

Drug	Company
Lidocaine	Cidara Therapeutics, Inc. (CDTX)

Phase 4(1)

Drug	Company
Lidocaine	Valneva SE (VALN)

BioSniper tracks 14 drugs in development for Morbid across 13 companies.

There are 1 clinical trial targeting Morbid tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.